Slate Medicines, Inc., 2026-03-11
An SEC Form D private-offering notice from Boston, MA, a $130,000,000 filer-stated offering target in Biotech. Filed 2026-03-11. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Biotech developing an anti-PACAP monoclonal antibody for the prevention of migraine and other headache disorders.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Everest Biolabs, Inc., 2026-03-11, $5.7M, Waltham, MA
- BioSolution Designs, Inc., 2026-03-12, $1.5M, Frederick, MD
- Aevius Labs, Inc., 2026-03-11, $2M, Boston, MA
- Nomizo Learning Labs, LLC, 2026-03-11, $1M, Westborough, MA
- DNA SEQ 2, INC., 2026-03-11, $1.2M, Vista, CA
- Solstice Oncology, Inc., 2026-03-09, $298.4M, Boston, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.